Versant Ventures
Venture capital Firm
Versant Ventures is a leading healthcare-focused venture capital firm specializing in early-stage investments in medical devices, biotechnology and pharmaceuticals, healthcare services, and healthcare information technology. The firm, founded in...Founded in 1999
Employees: 12
Homepage: http://www.versantventures.com
Suite 210
Menlo Park
USA CA
Phone: (650) 233-7877
Versant Ventures at CrunchBase
Donald Milder Managing Director, Co-Founder
Brian Atwood Co-Founder
Robin L. Praeger CFO
Ross A. Jaffe MD
Barbara Lubash Managing Director, Co-Founder
Camille Samuels Managing Director
Kevin Wasserstein Managing Director
Samuel D. Colella Founder & Managing Director
William Link Managing Director, Co-Founder
Bradley Bolzon Managing Director
Charles Warden Managing Director
Rebecca Robertson Managing Director
Past
April, 2013
Versant Ventures invested $43.2M in GenSight Biologics as a Series A round
March, 2013
Versant Ventures invested $8M in Theraclone Sciences as a Series B round
Versant Ventures invested $7.5M in Novira Therapeutics as a Series A round
February, 2013
Versant Ventures invested $10M in Holaira as a Series C round
Versant Ventures invested $30M in Glaukos as a Series F round
January, 2013
Versant Ventures invested $23.8M in Ocular Therapeutix as a Series D round
Versant Ventures invested $19.5M in Ceterix Orthopaedics as a Series B round
December, 2012
Versant Ventures invested $20M in Flexion Therapeutics as a Series B round
November, 2012
Versant Ventures invested $37.3M in CardiAQ Valve Technologies as a Series B round
October, 2012
Versant Ventures invested unknown amount in Cerephex as a Series A round
September, 2012
Versant Ventures invested $10.6M in Innovative Pulmonary Solutions as unattributed round
Versant Ventures invested $6M in ROX Medical as unattributed round
August, 2012
Versant Ventures invested $10M in Alter-G as a Series C round
June, 2012
Versant Ventures invested $25M in Benvenue Medical as a Series D round
May, 2012
Versant Ventures invested $25M in Zyga Technology as a Series C round
March, 2012
Versant Ventures invested $17M in OpGen as unattributed round
Versant Ventures invested $26M in Sequent Medical as a Series C round
December, 2011
Versant Ventures invested $6M in Groove Biopharma as a Series B round
November, 2011
Versant Ventures invested $8M in Advanced ICU Care as a Series D round
Versant Ventures invested $65M in AcuFocus as a Series F round
September, 2011
Versant Ventures invested $37.4M in Kythera Biopharmaceuticals as a Series D round
August, 2011
Versant Ventures invested $12M in Intuity Medical as a Series D round
May, 2011
Versant Ventures invested $15.9M in WaveTec Vision as a Series D round
April, 2011
Versant Ventures invested $35.5M in Benvenue Medical as a Series C round
January, 2011
Versant Ventures invested $3M in Augmenix as debt_round round
October, 2010
Versant Ventures invested $30M in Synosia Therapeutics as a Series C round
September, 2010
Versant Ventures invested $17M in OpGen as a Series B round
Versant Ventures invested $20.5M in Okairos as a Series B round
July, 2010
Versant Ventures invested $32M in Immune Design as a Series B round
June, 2010
Versant Ventures invested $28M in Veracyte as a Series B round
May, 2010
Versant Ventures invested $15.6M in Sequent Medical as a Series B round
April, 2010
Versant Ventures invested $3.9M in Mirina as a Series A round
January, 2010
Versant Ventures invested $64M in Intuity Medical as a Series D round
November, 2009
Versant Ventures invested $7.5M in Fluidigm as unattributed round
Versant Ventures invested $8.6M in Metabolex as unattributed round
October, 2009
Versant Ventures invested $6.1M in Augmenix as a Series B round
Versant Ventures invested $33M in Flexion Therapeutics as a Series A round
September, 2009
Versant Ventures invested $12.3M in Rennovia as a Series A round
June, 2009
Versant Ventures invested $15M in Ocular Therapeutix as a Series C round
Versant Ventures invested $9.4M in Transcend Medical as a Series A round
Versant Ventures invested $13M in Anaphore as a Series A round
May, 2009
Versant Ventures invested $145M in Clovis Oncology as a Series A round
April, 2009
Versant Ventures invested $15M in RedBrick Health as a Series C round
Versant Ventures invested $10M in Ambrx as a Series D round
March, 2009
Versant Ventures invested $22.4M in LensX Lasers as a Series B round
January, 2009
Versant Ventures invested $8M in Alter-G as a Series B round
Versant Ventures invested $29M in Synosia Therapeutics as a Series B round
October, 2008
Versant Ventures invested $21M in Cardiac Concepts as a Series B round
September, 2008
Versant Ventures invested $32M in APT Pharmaceuticals as a Series A round
Versant Ventures invested $22.5M in Microfabrica as a Series B round
August, 2008
Versant Ventures invested $35M in Glaukos as a Series D round
July, 2008
Versant Ventures invested $18M in Immune Design as a Series A round
June, 2008
Versant Ventures invested $9M in Vaccsys as unattributed round
May, 2008
Versant Ventures invested $30M in Kythera Biopharmaceuticals as a Series C round
Versant Ventures invested $49.5M in NovaSys as unattributed round
April, 2008
Versant Ventures invested $8M in Anaphore as unattributed round
March, 2008
Versant Ventures invested $14M in Cameron Health as a Series E round
February, 2008
Versant Ventures invested $19M in PhaseRx as a Series A round
January, 2008
Versant Ventures invested $15M in Benvenue Medical as a Series B round
September, 2007
Versant Ventures invested $23.6M in OpGen as a Series A round
April, 2007
Versant Ventures invested $32M in Metabolex as a Series D round
January, 2007
Versant Ventures invested $17M in Fluidigm as a Series E round
Versant Ventures invested $32.5M in Synosia Therapeutics as unattributed round
December, 2006
Versant Ventures invested $41M in NeoVista as a Series C round
November, 2006
Versant Ventures invested $5M in Impedance Cardiology Systems as a Series B round
Versant Ventures invested $35M in Neurotech as a Series B round
October, 2006
Versant Ventures invested $26M in Achaogen as a Series B round
September, 2006
Versant Ventures invested $26M in NeoVista as a Series B round
July, 2006
Versant Ventures invested $30M in Kythera Biopharmaceuticals as a Series B round
Versant Ventures invested $11M in Pathwork Diagnostics as unattributed round
April, 2006
Versant Ventures invested $10.8M in MedManage Systems as a Series D round
September, 2005
Versant Ventures invested $1M in Kythera Biopharmaceuticals as unattributed round
July, 2005
Versant Ventures invested $2.5M in Oxonica as unattributed round
February, 2005
Versant Ventures invested $45M in Five Prime Therapeutics as unattributed round
September, 2002
Versant Ventures invested $10M in Glaukos as a Series A round
1999
Versant Ventures was founded in 1999